"10.1371_journal.pone.0080573","plos one","2013-11-19T00:00:00Z","Kate M Scott; Karestan C Koenen; Sergio Aguilar-Gaxiola; Jordi Alonso; Matthias C Angermeyer; Corina Benjet; Ronny Bruffaerts; Jose Miguel Caldas-de-Almeida; Giovanni de Girolamo; Silvia Florescu; Noboru Iwata; Daphna Levinson; Carmen C W Lim; Sam Murphy; Johan Ormel; Jose Posada-Villa; Ronald C Kessler","Department of Psychological Medicine, University of Otago, Dunedin, New Zealand; Columbia Mailman School of Public Health, New York, New York, United States of America; Center for Reducing Health Disparities (CRHD), Community Engagement Program of the Clinical Translational Science Center (CTSC), University of California Davis, School of Medicine, Sacramento, California, United States of America; Health Services Research Unit, Institut Municipal d Investigacio Medica (IMIM-Hospital del Mar), and CIBER en Epidemiologıa y Salud Publica (CIBERESP), Barcelona, Spain; Center for Public Mental Health, Gösing/Wagram, Austria; Department of Epidemiologic and Psychosocial Research, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Leuven, Belgium; Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciencias Medicas, Universidade Nova de Lisboa, Lisbon, Portugal; IRCCS Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy; National School of Public Health, Management and Professional Development, Bucharest, Romania; Department of Clinical Psychology, Faculty of Psychological Sciences, Hiroshima International University, Hiroshima, Japan; Mental Health Services, Ministry of Health, Jerusalem, Israel; Department of Psychological Medicine, Otago University, Dunedin, New Zealand; Psychology Research Institute, School of Psychology, University of Ulster, Londonderry, Northern Ireland; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Colegio Mayor de Cundinamarca University, Bogota, DC, Colombia; Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, United States of America","Analyzed the data: KMS CCWL. Wrote the paper: KMS. Collected data, reviewed manuscript for intellectual content, and approved manuscript for submission: KMS KCK SAG JA MCA CB RB JMCA GG SF NI DL SM JO JPV RCK. Provided statistical advice: RCK.","Dr. Kessler has been a consultant for AstraZeneca, Analysis Group, Bristol-Myers Squibb, Cerner-Galt Associates, Eli Lilly & Company, GlaxoSmithKline Inc., HealthCore Inc., Health Dialog, Hoffman-LaRoche, Inc., Integrated Benefits Institute, John Snow Inc., Kaiser Permanente, Matria Inc., Mensante, Merck & Co, Inc., Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc., Primary Care Network, Research Triangle Institute, Sanofi-Aventis Groupe, Shire US Inc., SRA International, Inc., Takeda Global Research & Development, Transcept Pharmaceuticals Inc., and Wyeth-Ayerst. Dr. Kessler has served on advisory boards for Appliance Computing II, Eli Lilly & Company, Mindsite, Ortho-McNeil Janssen Scientific Affairs, Johnson & Johnson, Plus One Health Management and Wyeth-Ayerst. Dr. Kessler has had research support for his epidemiological studies from Analysis Group Inc., Bristol-Myers Squibb, Eli Lilly & Company, EPI-Q, GlaxoSmithKline, Johnson & Johnson Pharmaceuticals, Ortho-McNeil Janssen Scientific Affairs., Pfizer Inc., Sanofi-Aventis Groupe, Shire US, Inc., and Walgreens Co. He owns 25% share in DataStat, Inc. All other authors have no conflicts of interest to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.",NA,NA,NA,"2013","11","Kate M Scott","KMS",17,TRUE,NA,NA,2,1,TRUE,TRUE,FALSE,0,NA,FALSE
